Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if DFTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
79 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 16 days ago
Red flags: 0
361 filers reported a long position in DFTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $528.4M | 11.2M | +32.5% |
| Avoro Capital Advisors LLC | $338.2M | 7.2M | +43.8% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $322M | 6.8M | +15.8% |
| Jupiter Topco LLC | $264M | 5.6M | — |
| Capital World Investors | $252.5M | 5.4M | New |
| FMR LLC | $223.6M | 4.8M | +162.6% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $218.8M | 4.7M | +6,545.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $171.5M | 3.6M | +46.1% |
| STATE STREET CORP | $144.2M | 3.1M | +24% |
| Capital International Investors | $139.4M | 3M | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.